dotMD.com
IBS, Crohn, Colitis & Bowel Disorders • ICD-10-CM K90.0

Celiac Disease

Also known as: Celiac sprue, Gluten-sensitive enteropathy, Nontropical sprue

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM K90.0 • 4 Linked .gov / PubMed Citations • Governance: Dr. Devon Caldwell, DO, MPH (NPI #1568063758)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Celiac Disease Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Celiac Disease

3 of 3 Free Questions Remaining

What Is Celiac Disease?

What is celiac disease? Celiac disease is a chronic (long-term) digestive and immune disorder that damages your small intestine. The damage may prevent your body from absorbing vitamins , minerals , and other nutrients from the food you eat. This can lead to malnutrition and other serious health problems. Celiac disease is triggered by eating foods that contain gluten. Gluten is a protein found in wheat, barley, rye, and other grains. It may also be in other products you swallow like vitamins, supplements , toothpaste, mouthwash, and lip balm. Gluten in hair and skin products aren't absorbed through the skin.

Pathophysiology, Underlying Causes & Clinical Presentation

Underlying Celiac Disease (code K90.0) is mucosal tight-junction permeability in Celiac Disease (K90.0: shifts or immune-mediated), Cross-referenced with NIH MeSH (Celiac Disease), which IBS, Crohn, Colitis & Bowel Disorders clinicians address while surveilling hs-CRP, CBC & in Celiac Disease (K90.0: Ferritin) (Normal hemoglobin; hs-CRP < 1.0 mg/L (K90.0)).

Common Symptoms & Clinical Signs

  • • Have a family member who has the disease
  • • Have Down syndrome , Turner syndrome , or Williams syndrome
  • • Presentation of Celiac Disease (K90.0): alternating diarrhea, constipation, in Celiac Disease (K90.0: urgency, or sensation)
  • • Secondary Celiac Disease clinical sign: post-meal abdominal distension, in Celiac Disease (K90.0: gas bloating, or)

Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗

Celiac Disease Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code K90.0 WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub IBS, Crohn, Colitis & Bowel Disorders NIH MedlinePlus Health Topics
Diagnostic / Lab Marker: hs-CRP, CBC & in Celiac Disease (K90.0: Ferritin) Normal hemoglobin; hs-CRP < 1.0 mg/L (K90.0) Clinical Reference Target Range
Diagnostic / Lab Marker: Fecal Calprotectin [Celiac Disease K90.0] < 50 mcg/g (K90.0) Clinical Reference Target Range
Diagnostic / Lab Marker: Tissue Transglutaminase IgA in Celiac Disease (K90.0: (tTG-IgA)) Negative (celiac rule-out) (K90.0) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Celiac Disease

Check Drug Interactions →

Treatment selection for Celiac Disease depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Celiac Disease)

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
Can This Approach Help? Inside the Latest Research on Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of

The safety profile of ustekinumab across the pooled inflammatory bowel disease population through 1 year was favorable and generally comparable to placebo.

Inflammatory bowel diseases • 2021-06-15 • Phase III Randomized Trial
Multi-cohort 88/100 PMID 32964215 ↗
Zero-PHI Patient Support & Cohort Discussions

Celiac Disease Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Celiac Disease community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Celiac Disease.

Related Conditions in IBS, Crohn, Colitis & Bowel Disorders